期刊文献+

干扰素治疗慢性粒细胞白血病微量残留病疗效分析 被引量:3

Curative Effect of IFN-α on Minimum Residual Disease of Chronic Myelocytic Leukemia
暂未订购
导出
摘要 应用染色体技术和聚合酶链反应方法检测干扰素治疗慢性粒细胞白血病完全缓解后微量残留病28例的疗效。发现治疗后2例Ph'染色体阴转,长期应用干扰素组Ph'染色体阳性率下降,1例bcr/ab1mRNA转为阴性。而短期应用干扰素组无Ph'染色体变化,或bcr/ab1mRNA阴转。按目前我们应用干扰素的剂量、疗程,很难达到有效清除bcr/ab1mRNA阳性细胞的目的。 The curative effect of IFN-α on 28 cases of minimum residual disease (MRD)of chronic myelocylic leukemia (CML) after complete remission was studied by chromosometechnique and PCR. Two cases of ph' chromosome and one case of bcr/abl mRNA negativeconversions were found in the patients treated with IFN-α for 7~12 months. However, nonegative conversion of ph' chromosome or bcr/abl mRNA was found in those treated withIFN-α for 1~6 months. It indicated that bcr/abl mRNA positive cells could not be removedby IFN-α at current dosage and treatment course.
出处 《中国生物制品学杂志》 CAS CSCD 1998年第1期38-40,共3页 Chinese Journal of Biologicals
关键词 慢性 粒细胞 白血病 微量残留病 Α-干扰素 Chronic myelocytic leukemia Minimum residual disease IFN-α PCR bcr/abl mRNA
  • 相关文献

参考文献1

共引文献1

同被引文献9

  • 1邢秀华,王雷,王松酶,徐克惠,于向民.白血病bcr/abl mRNA的荧光定量RTP-CR检测[J].青岛大学医学院学报,2004,40(2):139-141. 被引量:7
  • 2袁长吉,迟宝荣,姚程,易永林.RT-PCR方法检测慢性粒细胞白血病bcr/abl融合基因类型[J].吉林大学学报(医学版),2004,30(5):750-752. 被引量:9
  • 3[3]Yokota H, Tsuno NH,Tanaka Y, et al. Quantification of minimal residual disease in patients with ela2 bcr-abl positive actue lymphoblastic leukemia using a real-time RTPCR assay. Leukemia, 2002,16(5): 1167-1175.
  • 4[6]Saffroy R, Lemoine A, Brezillon P,et al. Real-time quantitation of bcr-abl transcripts in haematological malignancies.Euro J Haematol,2000,65(2) ..258-267.
  • 5Yokota H,Tsuno NH,Tanaka Y,et al.Quantification of minimal residual disease in Patients with e1a2 her-abl positive actue lymphoblastic leukemia using a real-time RT-PCR assay[J].Leukemia,2002,16(3):1167.
  • 6Saffroy R,Lemoine A,Brezillon P,et al.Real-time quartitation of bcr-abl trarlscripts in haeematological malignancies[J].Euro J Haematol,2000,65(4):258-267.
  • 7Yokota H,Tsuno NH Tanaka Y,et al.Quantification of minimal residual disease in patients with ela2 bcr-abl-positive acute lymphoblastic leukemia using a teal-time.RT-PCR assay[J].Leukemia,2002,16:1167-1176.
  • 8严匡华,卞寿庚.p190慢性粒细胞白血病研究进展[J].中华血液学杂志,2003,24(6):332-334. 被引量:11
  • 9马晓霞,王椿.bcr/abl基因表达的定量检测技术及临床意义[J].白血病.淋巴瘤,2004,13(2):120-123. 被引量:7

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部